Cryo-Cell (CCEL) director granted 5,300 options at $4.35 on Oct 21, 2025
Cryo-Cell International (CCEL) director reported a new stock option grant.
Rhea-AI Filing Summary
Cryo-Cell International (CCEL) director reported a new stock option grant. On 10/21/2025, the director received options for 5,300 shares at an exercise price of $4.35, exercisable on 10/21/2025 and expiring on 10/21/2035. Following the reported transactions, the director directly beneficially owned 57,901 shares of common stock. The filing also lists multiple prior stock option awards with various exercise prices and maturities.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 5,300 shares
Grant/Award
9 txns
Insider
Berger Harold D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 5,300 | $4.35 | $23K |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 44,600 contracts for 39,300 underlying shares (Direct);
Common Stock — 57,901 shares (Direct)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CCEL disclose in this Form 4?
A director received a stock option grant for 5,300 shares at an exercise price of $4.35 on 10/21/2025.
What is the exercise price and term of the new CCEL options?
The options have an exercise price of $4.35, are exercisable on 10/21/2025, and expire on 10/21/2035.
What is the size of the new CCEL option grant?
The new grant covers 5,300 shares of CCEL common stock.
Who filed the CCEL Form 4?
A director of Cryo-Cell International filed the Form 4, as indicated by the checked relationship box and signature line.
Does the filing list other option awards?
Yes. The filing includes several prior stock option awards with different exercise prices and expiration dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
